Skip to main content

Table 3 Summary of findings in the endoscopic procedure at the end of treatments

From: Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial

Volunteer #

Treatment

Scores before treatment

Cryer Score

Lanza Score

Antrum

Duodenum

Other

2

Placebo

0

3

2

4 erosions

  

5

Placebo

0

2

1

1 erosion + submucousal hemorrage

  

7

Placebo

0

4

4

>20 erosions

  

8

Placebo

0

4

5

2 erosions + 1 ulcer (Sakita A2)

  

10

Placebo

0

4

4

>10 erosions

  

12

Placebo

0

4

5

10 erosions + 1 ulcer (Sakita A2)

  

14

Placebo

0

4

2

5 erosions

  

16

Placebo

0

4

4

20 erosions

  

17

Placebo

0

4

4

10 erosions

3 erosions

 

18

Placebo

0

4

4

10 erosions

  

19

Placebo

0

4

4

10 erosions

  

23

Placebo

0

4

4

10 erosions

  

1

Rebamipide

0

4

4

20–25 erosions

  

3

Rebamipide

0

4

4

10 erosions

  

4

Rebamipide

0

4

5

10 erosions

1 ulcer (Sakita A2)

 

6

Rebamipide

0

3

1

2 erosions + erythema

  

9

Rebamipide

0

3

2

3 erosions

  

11

Rebamipide

0

3

3

2 erosions

 

Submucousal hemorrhage in gastric fundus

13

Rebamipide

0

5

5

Small erosions + 2 ulcers (Sakita A2)

  

15

Rebamipide

0

4

2

5 erosions + erythema

  

20

Rebamipide

0

3

2

4 erosions

  

21

Rebamipide

0

4

5

  

Pylorus with edema and 1 ulcer (Sakita A2)

22

Rebamipide

0

3

2

3 erosions

  

24

Rebamipide

0

5

5

10 erosions + 4 ulcers (Sakita A2)